|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Eiger BioPharmaceuticals (NASDAQ: EIGR) through any online brokerage.
The latest price target for Eiger BioPharmaceuticals (NASDAQ: EIGR) was reported by Citigroup on August 9, 2021. The analyst firm set a price target for 27.00 expecting EIGR to rise to within 12 months (a possible 360.75% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Eiger BioPharmaceuticals (NASDAQ: EIGR) is $5.86 last updated Fri Dec 03 2021 21:00:04 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Eiger BioPharmaceuticals.
Eiger BioPharmaceuticals’s $Q3 earnings are confirmed for after-market on November 4, 2021.
There is no upcoming split for Eiger BioPharmaceuticals.
Eiger BioPharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.